Group One Trading’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-26,780
| Closed | -$130K | – | 6480 |
|
|
2020
Q1 | $130K | Buy |
26,780
+15,246
| +132% | +$98.8K | ﹤0.01% | 3094 |
|
|
2019
Q4 | $123K | Buy |
11,534
+10,772
| +1,414% | +$107K | ﹤0.01% | 3511 |
|
|
2019
Q3 | $8K | Sell |
762
-2,372
| -76% | -$31K | ﹤0.01% | 4668 |
|
|
2019
Q2 | $48K | Buy |
3,134
+2,426
| +343% | +$35.1K | ﹤0.01% | 3805 |
|
|
2019
Q1 | $9K | Buy |
+708
| New | +$8.01K | ﹤0.01% | 4328 |
|
|
2018
Q4 | – | Sell |
-5,088
| Closed | -$66K | – | 5719 |
|
|
2018
Q3 | $84K | Buy |
5,088
+1,122
| +28% | +$18K | ﹤0.01% | 3646 |
|
|
2018
Q2 | $64K | Buy |
+3,966
| New | +$70.8K | ﹤0.01% | 3824 |
|
|
2018
Q1 | – | Sell |
-1,384
| Closed | -$22K | – | 5558 |
|
|
2017
Q4 | $22K | Buy |
1,384
+75
| +6% | +$1K | ﹤0.01% | 4122 |
|
|
2017
Q3 | $15K | Buy |
+1,309
| New | +$12.3K | ﹤0.01% | 4183 |
|
|
2017
Q2 | – | Sell |
-3,274
| Closed | -$27.3K | – | 5302 |
|
|
2017
Q1 | $28K | Buy |
+3,274
| New | +$29.8K | ﹤0.01% | 3730 |
|
|
2016
Q1 | – | Sell |
-7,797
| Closed | -$49K | – | 5179 |
|
|
2015
Q4 | $49K | Sell |
7,797
-2,200
| -22% | -$17.9K | ﹤0.01% | 3422 |
|
|
2015
Q3 | $88K | Buy |
+9,997
| New | +$105K | ﹤0.01% | 3132 |
|
Group One Trading's STML Position: Q2 2020 in Review
Group One Trading sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 26,780 shares — an estimated $130K sold.
Group One Trading first reported a position in STML in Q3 2015 and held it in 12 quarters. The position peaked at $130K in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- Group One Trading reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- Group One Trading sold 26,780 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $130K.
- Group One Trading first reported a position in Stemline Therapeutics, Inc. in Q3 2015 and held it in 12 quarters.
- Group One Trading's Stemline Therapeutics, Inc. position peaked at $130K in Q1 2020.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.